Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi

PLoS Neglected Tropical Diseases

Volumn 5, Issue 3, 2011, Pages

  Eickhoff, Christopher S ^a   Vasconcelos, Jose R ^a,b   Sullivan, Nicole L ^a   Blazevic, Azra ^a   Bruna Romero, Oscar ^c   Rodrigues, Mauricio M ^b   Hoft, Daniel F ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 15; INTERLEUKIN 2; PLASMID DNA; SIALIDASE; TETRAMER; TUMOR NECROSIS FACTOR ALPHA; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; CYTOKINE; DNA VACCINE; GLYCOPROTEIN; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; PROTOZOAL VACCINE; PROTOZOON ANTIBODY; RECOMBINANT VACCINE; TRANS SIALIDASE; TRANS-SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE CONSTRUCT; GENETIC CODE; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LONG TERM CARE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PROVOCATION TEST; TRYPANOSOMA CRUZI; ANIMAL; BAGG ALBINO MOUSE; BLOOD; GENETICS; IMMUNOLOGY; PLASMID; SECRETION; SURVIVAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; GLYCOPROTEINS; INTERLEUKIN-15; MICE; MICE, INBRED BALB C; NEURAMINIDASE; OLIGODEOXYRIBONUCLEOTIDES; PLASMIDS; PROTOZOAN VACCINES; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 79953800141     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000983     Document Type: Article

References (31)

1. CDC, (2007) Blood donor screening for Chagas disease-United States, 2006-2007. MMWR Morb Mortal Wkly Rep 56: 141-143.
2. World Health Organization (2010) http://www.who.int/neglected_diseases/diseases/chagas/en/index.html.
3. Hoft DF, Eickhoff CS, Giddings OK, Vasconcelos JR, Rodrigues MM, (2007) Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J Immunol 179: 6889-6900.
4. Costa F, Franchin G, Pereira-Chioccola VL, Ribeirao M, Schenkman S, et al. (1998) Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16: 768-774.
5. Santori FR, Paranhos-Bacalla GS, Franco DS, Yamauchi LM, Araya JE, et al. (1996) A recombinant protein based on the Trypanosoma cruzi metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection. Infect Immun 64: 1093-1099.
6. Yoshida N, Araya JE, da Silveira JF, Giorgio S, (1993) Trypanosoma cruzi: antibody production and T cell response induced by stage-specific surface glycoproteins purified from metacyclic trypomastigotes. Exp Parasitol 77: 405-413.
7. Araujo AF, de Alencar BC, Vasconcelos JR, Hiyane MI, Marinho CR, et al. (2005) CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect Immun 73: 6017-6025.
8. Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, et al. (2004) Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 15: 878-886.
9. Eickhoff CS, Giddings OK, Yoshida N, Hoft DF, (2010) Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 105: 687-691.
10. Garg N, Tarleton RL, (2002) Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 70: 5547-5555.
11. Abuin G, Freitas-Junior LH, Colli W, Alves MJ, Schenkman S, (1999) Expression of trans-sialidase and 85-kDa glycoprotein genes in Trypanosoma cruzi is differentially regulated at the post-transcriptional level by labile protein factors. J Biol Chem 274: 13041-13047.
12. Frevert U, Schenkman S, Nussenzweig V, (1992) Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi. Infect Immun 60: 2349-2360.
13. Machado AV, Cardoso JE, Claser C, Rodrigues MM, Gazzinelli RT, et al. (2006) Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 17: 898-908.
14. Hoft DF, Eickhoff CS, (2005) Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infect Immun 73: 4934-4940.
15. Giddings OK, Eickhoff CS, Smith TJ, Bryant LA, Hoft DF, (2006) Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infect Immun 74: 5549-5560.
16. Yan J, Reichenbach DK, Corbitt N, Hokey DA, Ramanathan MP, et al. (2009) Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen. Vaccine 27: 431-440.
17. Yang JS, Kim JJ, Hwang D, Choo AY, Dang K, et al. (2001) Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). J Infect Dis 184: 809-816.
18. Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, et al. (2005) Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 175: 112-123.
19. Costa F, Franchin G, Pereira-Chioccola VL, Ribeirao M, Schenkman S, et al. (1998) Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16: 768-774.
20. Rodrigues MM, Ribeirao M, Pereira-Chioccola V, Renia L, Costa F, (1999) Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect Immun 67: 3855-3863.
21. Pereira-Chioccola VL, Costa F, Ribeirao M, Soares IS, Arena F, et al. (1999) Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein. Parasite Immunol 21: 103-110.
22. Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, et al. (2009) Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. Vaccine 27: 4370-4380.
23. Toka FN, Rouse BT, (2005) Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. J Leukoc Biol 78: 178-186.
24. Khan IA, Casciotti L, (1999) IL-15 prolongs the duration of CD8 + T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. J Immunol 163: 4503-4509.
25. Dubois S, Mariner J, Waldmann TA, Tagaya Y, (2002) IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17: 537-547.
26. Osborne LC, Abraham N, (2010) Regulation of memory T cells by gammac cytokines. Cytokine 50: 105-113.
27. Hoft DF, Schnapp AR, Eickhoff CS, Roodman ST, (2000) Involvement of CD4+ Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect Immun 68: 197-204.
28. Bulanova E, Budagian V, Pohl T, Krause H, Durkop H, et al. (2001) The IL-15R alpha chain signals through association with Syk in human B cells. J Immunol 167: 6292-6302.
29. Oh S, Berzofsky JA, Burke DS, Waldmann TA, Perera LP, (2003) Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci U.S.A. 100: 3392-3397.
30. Wizel B, Nunes M, Tarleton RL, (1997) Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J Immunol 159: 6120-6130.
31. Katae M, Miyahira Y, Takeda K, Matsuda H, Yagita H, Okumura K, Takeuchi T, Kamiyama T, Ohwada A, Fukuchi Y, Aoki T, (2002) Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy. Infect Immun 70: 4833-4840.